Audentes Therapeutics (BOLD) Tops Q1 EPS by 6c

May 9, 2018 4:24 PM

Audentes Therapeutics (NASDAQ: BOLD) reported Q1 EPS of ($0.74), $0.06 better than the analyst estimate of ($0.80).

For earnings history and earnings-related data on Audentes Therapeutics (BOLD) click here.

Categories

Earnings Guidance